Smith, Moore & Co.
- SEC CIK
- 0000200724
- Latest filing
- Aug 12, 2026
GSK holding history
GSK plc in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −9,782−100.0% | Sold out | Holders |
| Q2 2022 | 9,782 | $426.0K | 0.1% | −800−7.6% | Reduced | Holders |
| Q1 2022 | 10,582 | $461.0K | 0.1% | −481−4.3% | Reduced | Holders |
| Q4 2021 | 11,063 | $488.0K | 0.1% | +541+5.1% | Added | Holders |
| Q3 2021 | 10,522 | $402.0K | 0.1% | −41−0.4% | Reduced | Holders |
| Q2 2021 | 10,563 | $421.0K | 0.1% | +1,380+15.0% | Added | Holders |
| Q1 2021 | 9,183 | $328.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.